Skip to main
UNH

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 21 analyst ratings
Buy
Strong Buy 29%
Buy 57%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

UnitedHealth Group is a leading player in the healthcare market, with a strong financial performance due to its diversified business model and solid management team. Despite some challenges in the commercial segment, growth in the Medicare Advantage segment and the implementation of AI technology leaves the company with a positive outlook for achieving its long-term EPS growth target. However, it is important to consider potential risks and challenges such as managing medical costs, network contracts, and government regulations that could impact their rating and price target.

Bears say

UnitedHealth Group is a dominant player in the healthcare industry with a strong focus on employer-sponsored and government-backed insurance plans. While its Medicare Advantage business segment has performed well, there are concerns about potential investigations and regulatory challenges in the highly regulated industry. Additionally, the company's Optum Health initiatives are expected to drive growth in the future with improved care management and productivity, but there may be a potential risk from commercial pressures. Overall, while UnitedHealth Group has demonstrated strong financial performance, the negative outlook is based on potential challenges and risks in the future, particularly in the commercial market.

UnitedHealth Group (UNH) has been analyzed by 21 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 57% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 21 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $454.76, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $454.76, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.